Abstract: The invention provides novel &bgr;-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic &bgr;-lactamase inhibitors presently available, and which do not possess a &bgr;-lactam pharmacophore. These new inhibitors are fully synthetic, allowing ready access to a wide variety of structurally related analogs. Certain embodiments of these new inhibitors also bind bacterial DD-peptidases, thus potentially acting both as &bgr;-lactamase inhibitors and as antibiotics.
Type:
Grant
Filed:
March 1, 2001
Date of Patent:
July 29, 2003
Assignee:
MethylGere, Inc.
Inventors:
Jeffrey M. Besterman, Jubrail Rahil, Rex Pratt